Matthew Kuhlmeier Email

Facilities & IT Director . Haematologic Technologies

Current Roles

Employees:
74
Revenue:
$11.5M
About
Haematologic Technologies (HTI) is the leading provider of reagents for coagulation research and analytical services to support the research, development and commercialization of large molecule biotherapeutics. HTI has deep expertise in protein biochemistry including characterization of plasma proteins and other large molecules, and performs highly advanced assay development and GMP testing in the areas of immunoassays, thrombin generation assays, assessment of hemostatic risk, anti-drug antibody testing (immunogenity), host cell protein mitigation, stability and release testing, as well as a variety of other specialized assays for biotherapeutics supporting discovery through commercial release. The company's biopharma services are performed in fully compliant, FDA-inspected GMP facilities. Building on its 30+ years of expertise in plasma proteins, hemostasis and blood coagulation, HTI is also a leading global supplier of coagulation research reagents (plasma proteins and antibodies), custom formulated IVD/POC device reagents, as well as customized blood collection tubes to support clinical trials. Visit us at www.haemtech.com.
Haematologic Technologies Address
57 River Road
Essex Junction, VT
United States
Haematologic Technologies Email
Haematologic Technologies Phone Numbers
802-878-1777

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.